Loading organizations...
§ Private Profile · Syracuse, NY, USA
Small molecule-based platform for bone growth and pain reduction.
ZetaGen Therapeutics has raised $22.7M across 2 funding rounds.
ZetaGen Therapeutics has raised $22.7M in total across 2 funding rounds.
ZetaGen Therapeutics has raised $22.7M across 2 funding rounds. Most recently, it raised $12.9M Series B in November 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 25, 2025 | $12.9M Series B | Jstar Capital Investments | — | Announced |
| Aug 11, 2023 | $9.8M Series B | — | NEW York Ventures | Announced |
ZetaGen Therapeutics has raised $22.7M in total across 2 funding rounds.
ZetaGen Therapeutics's investors include JSTAR Capital Investments, New York Ventures.